Over the past decade, extra-adrenal
cortisol production was reported in various tissues. The
enzyme that catalyzes the conversion of hormonally inactive
cortisone into active
cortisol in cells is 11β-hydroxysteroid
dehydrogenase 1 (11β-HSD1). We recently reported that 11β-HSD1 is also expressed in keratinocytes and regulates
inflammation and keratinocyte proliferation. To investigate the function of 11β-HSD1 in keratinocytes during
inflammation in vivo, we created keratinocyte-specific 11β-HSD1 knockout (K5-Hsd11b1-KO) mice and analyzed the inflammatory response in models of
hapten-induced contact
irritant dermatitis. K5-Hsd11b1-KO mice showed enhanced ear swelling in low-dose
oxazolone-,
2,4,6-trinitro-1-chlorobenzene (TNCB)-, and 2,4-dinitrofluorobenzene-induced
irritant dermatitis associated with increased inflammatory cell infiltration. Topical application of
corticosterone dose dependently suppressed TNCB-induced ear swelling and
cytokine expression. Similarly in mouse keratinocytes in vitro,
corticosterone dose dependently suppressed 2,4,6-trinitrobenzenesulfonic
acid-induced IL-1α and IL-1β expression. The effect of
11-dehydrocorticosterone was attenuated in TNCB-induced
irritant dermatitis in K5-Hsd11b1-KO mice compared with wild-type mice. In human samples, 11β-HSD1 expression was decreased in epidermis of
psoriasis vulgaris compared with healthy skin. Taken together, these data suggest that
corticosterone activation by 11β-HSD1 in keratinocytes suppresses
hapten-induced
irritant dermatitis through suppression of expression of
cytokines, such as IL-1α and IL-1β, in keratinocytes.